SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Biolase Q1 EPS $(0.190) Misses $(0.140) Estimate, Sales $4.700M Miss $4.980M Estimate

Biolase (NASDAQ:BIOL) reported quarterly losses of $(0.190) per share which missed the analyst consensus estimate of $(0.140) by 35.71 percent. This is a 26.67 percent decrease over losses of $(0.150) per share from the

Benzinga · 05/07/2020 20:21

Biolase (NASDAQ:BIOL) reported quarterly losses of $(0.190) per share which missed the analyst consensus estimate of $(0.140) by 35.71 percent. This is a 26.67 percent decrease over losses of $(0.150) per share from the same period last year. The company reported quarterly sales of $4.700 million which missed the analyst consensus estimate of $4.980 million by 5.62 percent. This is a 54.48 percent decrease over sales of $10.326 million the same period last year.